Foghorn Therapeutics Inc.
FHTX
|
|
| |
|
| Trading Volume | 12,342 |
|
|
8.39 - 2.82 |
| Market Cap Full | $ 329.3M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.5% | 4.2% | -2.8% | -34.3% |
| Q2 | - | -19.7% | 13.6% | -11.5% |
| Q3 | - | 10.6% | -29% | -36.9% |
| Q4 | - | -49.1% | 45.3% | -25.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.5 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -50.7 | 143.1 | -13.1 | -19.9 | 9.1 | -2 | 22.6 | 10.6 | - | - | - | -40.8 |
| 2023 | |||||||||||
| 34.8 | -33.4 | 8.2 | 5.2 | -3.5 | 11.9 | 30.1 | -17.4 | -34 | -33 | 26.9 | 51.8 |
| 2022 | |||||||||||
| -34.2 | -36.4 | 57.1 | -24.5 | 11.3 | 5.4 | 7.6 | -32.1 | -13.7 | 1.9 | -22.8 | -5.5 |
| 2021 | |||||||||||
| -22.8 | 5.2 | -19.9 | -16.7 | -7.2 | 4.7 | -15 | 43.1 | 7.3 | -8.9 | -8.8 | 101.9 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | 26.4 | 0.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.7 | -0.7 | -0.6 | 0 |
| Q2 | -0.7 | -0.7 | -0.6 | 0 |
| Q3 | -0.3 | -0.6 | -0.7 | 0 |
| Q4 | 0 | -0.7 | -0.8 | 0 |
| A | -1.77 | -2.6 | -2.7 | -6.2 |